PathoAI
PrivateLast Round
Series A
Aug 4, 2025
Total Funding Raised
$2.78M
Company Overview
PathoAI is a healthcare technology company that develops AI-powered products and digital solutions for pathology diagnostics and pharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathoAI Comparables
Compare PathoAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thorough Future | 89% | |
| Hangzhou DiPath Technology Co., Ltd. | 87% | |
| Qritive | 86% |
PathoAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 4, 2025 | ||||
| Angel | Nov 1, 2024 | ||||
| Angel | May 25, 2023 | ||||
| Angel | May 24, 2023 | ||||
| Pre Seed | Mar 16, 2021 |
PathoAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yangzhou Balance Yichuang Venture Fund | Angel |
| Hangzhou Oufang Venture Capital Management | Series A, Angel |
| Taikun Fund | Angel |
PathoAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PathoAI's valuation, stock price, and market status.
Is PathoAI a public or private company?
PathoAI is a private company.
What is the current stock price of PathoAI?
PathoAI is a private company, so its shares have no public market price. Caplight tracks PathoAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PathoAI worth (valuation)?
Valuation information for PathoAI is not publicly available.
Can I buy PathoAI stock?
PathoAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PathoAI's last funding round?
PathoAI's most recent funding round was Series A on August 4, 2025.
Who are the main investors in PathoAI?
Key investors in PathoAI include Taikun Fund.
Will PathoAI IPO soon?
No public IPO plans have been announced for PathoAI.
How can I track PathoAI secondary market activity?
Caplight tracks bids, offers, and trades in PathoAI's shares on secondary markets.